All news
>
EIT Catapult semi-finalist

EIT Catapult semi-finalist

PepKon
October 21, 2024
PepKon is proud to be a semi-finalist in the EIT Catapult program, joining the top 30 European start-ups. This recognition underscores PepKon’s innovation in oncology and supports its growth with visibility and resources. This milestone reinforces PepKon’s commitment to advancing peptide therapies and moving towards clinical development.

PepKon is proud to be a semi-finalist in the EIT Catapult program, joining the top 30 European start-ups. This recognition underscores PepKon’s innovation in oncology and supports its growth with visibility and resources.This milestone reinforces PepKon’s commitment to advancing peptide therapies and moving towards clinical development.

Find other news

Bio-Europe 2024

Bio-Europe 2024

PepKon is pleased to announce its participation at BIO-Europe in Stockholm from November 3-5. This major event brings together key players in the biotech and pharmaceutical industries, offering unique opportunities for networking, partnerships, and showcasing innovative research.